Skip to main content

Cardiovascular News

News
Inadequate management of a patient’s depression following heart attack or stroke is linked with notably higher health care costs, according to a study published online in the Journal of Medical Economics.  The US-based retrospective study looked at health care resource use and cost data for 1568…
News
By Reuters Staff (Reuters) - Drugmaker Amgen Inc said on Thursday that starting next year, its official list price for cholesterol drug Repatha (evolocumab) will be the lower price it began offering last year to patients on Medicare and those paying for the drug out-of-pocket. The company…
News
Researchers from Rush Medical College found that spending on diabetes medications as well as high blood pressure medications was lower among patients who underwent weight-loss surgery. The findings of the study were presented at the American Society for Metabolic and Bariatric Surgery (ASMBS)…
News
By Lisa Rapaport (Reuters Health) - With increased access to insurance under the Affordable Care Act (ACA), fewer middle-aged people are dying from heart disease, a U.S. study suggests. Under the ACA, some U.S. states expanded coverage through Medicaid - a joint federal and state insurance…
News
Out-of-pocket spending for beta-blockers was significantly linked with a slight decline in medication adherence among Medicare Part D enrollees with heart failure, according to a study in the Journal of Managed Care & Specialty Pharmacy. “This finding corroborates an earlier study in a…
News
To reduce lifetime risk for atherosclerotic cardiovascular disease, new cholesterol management guidelines from the American Heart Association, the American College of Cardiology, and other prevention-oriented societies recommend a heart-healthy lifestyle beginning in childhood. A synopsis of the…
News
By Megan Brooks NEW YORK (Reuters Health) - A clinical decision support tool powered by artificial intelligence (AI) can prevent unnecessary diagnostic tests in patients with stable chest pain, according to new research. "We know that doctors over-test patients and ignore recommendations about…
Conference Insider
During a session at ISPOR 2019, Naomi Sacks, PhD, director of Evidence Strategy and Generation at Precision Xtract, discussed the costs associated with paroxysmal supraventricular tachycardia (PSVT) and explained why costs differ depending on patient age and disease onset. Dr Sacks kicked off her…
News
Regeneron and Sanofi revealed in a press release today plans to reduce the cost of their cholesterol treatment drug, Praluent (alirocumab), by 60%. This decision is one in a series of choices to make Praluent more available and affordable to patients. The new price will be $5,850 annually…
Newsfeed
By Marilynn Larkin NEW YORK (Reuters Health) - Medicaid expansion has led to declines in uninsured acute myocardial infarction (AMI) hospitalizations, but in-hospital care quality has remained unchanged, researchers say. Dr. Karen Joynt Maddox of Washington University School of Medicine in St.…
Back to Top